Hepatitis A.
There are exciting new developments in the serology of hepatitis A. These new studies will lead to the development of diagnostic tests comparable to the Australia antigen (HBsAg) for hepatitis B. Although active immunization is not likely to be available in the near future, passive immunization is effective. Most patients with clinical disease will recover uneventfully with good diet and ad lib activity. Severe restrictions and hospitalization are rarely indicated.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000032:analysis; D001780:Blood Coagulation Tests; D002779:Cholestasis / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D006506:Hepatitis A / Q000175:diagnosis / Q000628:therapy / Q000635:transmission; D006801:Humans; D007565:Jaundice / Q000209:etiology; D009708:Nucleotidases / Q000097:blood; D012698:Serologic Tests; D012709:Serum Albumin / Q000032:analysis; D014556:Urine / Q000032:analysis
D012709:Serum Albumin; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009708:Nucleotidases; D000469:Alkaline Phosphatase; D001663:Bilirubin